NASDAQ:IOVA
Iovance Biotherapeutics, Inc.
- Stock
Last Close
2.31
06/11 22:32
Market Cap
2.18B
Beta: 0.20
Volume Today
10.67M
Avg: 3.51M
PE Ratio
−4.56
PFCF: −7.39
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 1.19M - | 164.07M 13,698.99% | ||||||||||
cost of revenue | 9.34M - | 33.13M - | 124.00M 274.30% | |||||||||
gross profit | -9.34M - | -31.94M - | 40.08M 225.48% | |||||||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 9.34M - | 12.39M 32.72% | 25.60M 106.63% | 21.26M 16.95% | 28.43M 33.71% | 40.85M 43.68% | 60.21M 47.40% | 83.66M 38.95% | 104.10M 24.42% | |||
selling general and administrative expenses | 9.34M - | 12.39M 32.72% | 25.60M 106.63% | 21.26M 16.95% | 28.43M 33.71% | 40.85M 43.68% | 60.21M 47.40% | 83.66M 38.95% | 104.10M 24.42% | 84.54M 18.78% | 153.02M 80.99% | |
research and development expenses | 2.70M - | 15.47M 471.99% | 28.04M 81.23% | 71.61M 155.43% | 99.83M 39.40% | 166.02M 66.31% | 201.73M 21.51% | 259.04M 28.41% | 294.78M 13.80% | 344.08M 16.72% | 282.34M 17.94% | |
other expenses | ||||||||||||
cost and expenses | 12.04M - | 27.86M 131.39% | 53.64M 92.53% | 92.88M 73.15% | 128.26M 38.09% | 206.87M 61.29% | 261.94M 26.62% | 342.70M 30.83% | 398.88M 16.39% | 461.75M 15.76% | 559.35M 21.14% | |
operating expenses | 12.04M - | 27.86M 131.39% | 53.64M 92.53% | 92.88M 73.15% | 128.26M 38.09% | 206.87M 61.29% | 261.94M 26.62% | 342.70M 30.83% | 398.88M 16.39% | 428.62M 7.46% | 435.35M 1.57% | |
interest expense | 5.66K - | 200K 3,433.57% | 2.98M - | |||||||||
ebitda | -11.95M - | -27.86M 133.10% | -53.64M 92.53% | -92.88M 73.15% | -128.26M 38.09% | -206.87M 61.29% | -260.80M 26.07% | -342.70M 31.41% | -398.88M 16.39% | -427.43M 7.16% | -351.67M 17.72% | |
operating income | -12.04M - | -27.86M 131.39% | -53.64M 92.53% | -92.88M 73.15% | -128.26M 38.09% | -206.87M 61.29% | -261.94M 26.62% | -342.70M 30.83% | -398.88M 16.39% | -460.56M 15.46% | -395.28M 14.17% | |
depreciation and amortization | 88.22K - | 999K 1,032.38% | 978K 2.10% | 952K 2.66% | 956K 0.42% | 1.17M 22.28% | 1.14M 2.48% | 13.98M 1,126.32% | 21.14M 51.18% | 33.13M 56.74% | 43.61M 31.63% | |
total other income expenses net | 5.66K - | 200K 3,433.57% | 745K 272.50% | 813K 9.13% | 4.68M 475.40% | 9.32M 99.14% | 2.36M 74.71% | 451K 80.86% | 2.98M 561.86% | 13.04M 336.95% | 20.27M 55.43% | |
income before tax | -12.03M - | -27.66M 129.84% | -52.89M 91.23% | -92.06M 74.05% | -123.58M 34.23% | -197.56M 59.86% | -259.58M 31.40% | -342.25M 31.85% | -395.89M 15.67% | -447.52M 13.04% | -375.00M 16.20% | |
income tax expense | -999K - | -978K 2.10% | -952K 2.66% | 4.68M 591.39% | -10.48M 324.13% | -2.36M 77.53% | -14.43M 512.52% | -5.97M 58.63% | -3.48M 41.73% | -2.83M 18.71% | ||
net income | -12.03M - | -27.66M 129.84% | -52.89M 91.23% | -92.06M 74.05% | -123.58M 34.23% | -187.07M 51.38% | -257.23M 37.50% | -327.82M 27.45% | -389.92M 18.94% | -444.04M 13.88% | -372.18M 16.18% | |
weighted average shs out | 24.99M - | 44.41M 77.74% | 55.27M 24.45% | 65.24M 18.05% | 97.28M 49.10% | 124.34M 27.82% | 138.30M 11.23% | 153.41M 10.92% | 159.26M 3.82% | 235.13M 47.64% | 289.88M 23.28% | |
weighted average shs out dil | 24.99M - | 44.41M 77.74% | 55.27M 24.45% | 65.24M 18.05% | 97.28M 49.10% | 124.34M 27.82% | 138.30M 11.23% | 153.41M 10.92% | 159.26M 3.82% | 235.13M 47.64% | 289.88M 23.28% | |
eps | -0.48 - | -0.62 29.17% | -0.96 54.84% | -1.41 46.87% | -1.27 9.93% | -1.50 18.11% | -1.86 24.00% | -2.14 15.05% | -2.45 14.49% | -1.89 22.86% | -1.28 32.28% | |
epsdiluted | -0.48 - | -0.62 29.17% | -0.96 54.84% | -1.41 46.87% | -1.27 9.93% | -1.50 18.11% | -1.86 24.00% | -2.14 15.05% | -2.45 14.49% | -1.89 22.86% | -1.28 32.28% |
All numbers in USD (except ratios and percentages)